20 results
424B5
ABOS
Acumen Pharmaceuticals Inc
20 Jul 23
Prospectus supplement for primary offering
4:11pm
that is classified as a partnership for U.S. federal income tax purposes holds our common stock, the U.S. federal income tax treatment of a partner … the our bylaws, the classified board, the size of the our board, removal of directors, director liability, vacancies on the our board, special meetings
424B5
ttmc98b2d6ra0q1o
17 Jul 23
Prospectus supplement for primary offering
4:49pm
S-3
plm6ohz
1 Jul 22
Shelf registration
5:06pm
10-K
EX-4.2
siyxv
28 Mar 22
Annual report
4:51pm
10-K
r7te48ws5u92b qi73h
28 Mar 22
Annual report
4:51pm
10-Q
f4179ugv6zpl1d7toa
16 Aug 21
Quarterly report
4:51pm
424B4
jmt6klmq
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
01jyh53lh8g8o0q39tn4
24 Jun 21
IPO registration (amended)
8:17am
S-1
jw2r2hr
9 Jun 21
IPO registration
5:02pm
DRS/A
lnxlf jfh3axh
14 May 21
Draft registration statement (amended)
12:00am
DRS
cls nufsg
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next